SA39 Targeted Treatments for Patients with Relapsed and/or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): A Systematic Literature Review (SLR) of Randomized Clinical Trials (RCTs)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2948
https://www.valueinhealthjournal.com/article/S1098-3015(23)06079-5/fulltext
Title :
SA39 Targeted Treatments for Patients with Relapsed and/or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): A Systematic Literature Review (SLR) of Randomized Clinical Trials (RCTs)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)06079-5&doi=10.1016/j.jval.2023.09.2948
First page :
Section Title :
Open access? :
No
Section Order :
12276